Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | BCL9 | O00512 | 2/20 | 0.37 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ESRRG | P62508 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27193274 | 0.87 | PTPN1 (0.55) | PTPN1MCHR1NPC1RAB9AMEN1 | |
| SCHEMBL27193269 | 0.83 | MCHR1 (0.47) | PTPN1MCHR1BCL9CTNNB1HTR2C | |
| SCHEMBL27193258 | 0.82 | MCHR1 (0.46) | MCHR1BCL9CTNNB1HTR2C | |
| SCHEMBL27193288 | 0.78 | ALDH1A1 (0.51) | PTPN1MCHR1NPC1RAB9AKMT2A | |
| SCHEMBL27193296 | 0.76 | HTR1D (0.43) | PTPN1MCHR1NPC1RAB9ABCL9 | |
| SCHEMBL27193249 | 0.73 | RAB9A (0.54) | PTPN1MCHR1NPC1RAB9AMEN1 | |
| SCHEMBL27193247 | 0.72 | MAPT (0.51) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL27193307 | 0.72 | MAPT (0.55) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL27193260 | 0.71 | MAPT (0.55) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL27193221 | 0.70 | NPC1 (0.58) | PTPN1MCHR1NPC1RAB9AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | SAINT LOUIS UNIVERSITY (US) | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | ABCC1, ARG1, SLC11A2 | PTPN1 937/4885MCHR1 3913/4885NPC1 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.